Compare GoPro Inc (GPRO) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GoPro Inc vs IDEXX Laboratories, Inc. — how do they compare? GoPro Inc trades at $0.59 (market cap $114.41M), while IDEXX Laboratories, Inc. trades at $573.46 (market cap $46.22B). The key difference: IDEXX Laboratories, Inc. is far larger — about 404× GoPro Inc's market cap, and IDEXX Laboratories, Inc. is trading nearer its 52-week high, GoPro Inc nearer its low. Which is the better fit depends on your goals.
| GPRO | IDXX | |
|---|---|---|
Market Cap | $114.41M | $46.22B |
Sector | Technology | Health |
52-Week High | $2.88 | $766.68 |
52-Week Low | $0.62 | $526.44 |
Enterprise Value | $173.19M | $47.12B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GoPro (GPRO) trades at $0.57, down 18.48% in the last session, reflecting ongoing operational challenges. The company shows deteriorating fundamentals with negative net income margins (-28.52%) and consecutive earnings misses. Technical indicators signal bearish momentum, while cash flow remains negative. Recent news highlights a strategic review process for potential sale alternatives as the company faces significant financial stress.
The outlook remains highly speculative with substantial execution risks. Investment opportunity hinges entirely on successful strategic alternatives, while risks include persistent cash burn, competitive pressures, and potential dilution from recent financing. The stock presents a binary outcome scenario dependent on corporate action success.
IDEXX Laboratories (IDXX) trades at $571.44, down 4.08% over the past day, amid a mixed technical and strong fundamental backdrop. The stock shows a bullish trend in moving averages but overbought RSI readings near 73. Recent Q2 2026 earnings beat expectations with 9% organic revenue growth, and the company raised full-year EPS guidance. Profitability remains robust with a 25.03% net income margin and 74.21% ROE.
The outlook is positive given strong earnings momentum, high analyst buy ratings, and a consensus price target of $683.33 implying ~20% upside. Risks include premium valuation multiples and potential market volatility. The stock presents a growth opportunity supported by durable competitive advantages in veterinary diagnostics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GoPro Inc
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
Read more on GPRO →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
